Notice of Acceptance of patent in Australia

RNS Number : 7097Q

Eden Research plc

09 November 2012

 



EDEN RESEARCH PLC

("Eden" or "Company")

Notice of Acceptance of patent in Australia

Eden Research plc, the agrochemical and encapsulation development company, announces that it has received a Notice of Acceptance from the Commonwealth of Australia Patent Office for one of its composition patents.

The patent covers the use of the Company's core technology as part of a composition which is effective in killing insects and arachnids. The patent is relevant to agrochemical applications of Eden's technology, particularly in providing a safe, effective and environmentally friendly alternative to existing chemical pesticides used to protect vegetables, orchards and glasshouse crops.

The Patent, number 2006321415, which expires in 2026, was jointly developed with Cornell University, USA, and was subsequently licensed to Eden on an exclusive basis in September 2011.

Clive Newitt, Managing Director of Eden said, "The acceptance of another formulation patent further strengthens Eden's intellectual property portfolio as the claims allowed provide wide coverage in a sector where we have already shown good efficacy in study trials, minimal impact upon other beneficial predator insects used by growers in Integrated Pest Management programmes and where discussions with potential licensing partners are already underway."

This follows on from the Grant of Patent from the Commonwealth of Australia Patent Office for its platform encapsulation technology announced in April 2012.

Eden Research plc	www.edenresearch.com
Clive Newitt, Managing Director	Tel: [phone]
Alex Abrey, Chief Financial Officer
Zeus Capital Limited
Ross Andrews / Andrew Jones	Tel: [phone]
John Goold (Institutional Sales)	Tel: [phone]
Walbrook PR Ltd	Tel: [phone]
Paul McManus (Media Relations)	Mob: [phone] or [e-mail]
Paul Cornelius (Investor Relations)	Mob: [phone] or [e-mail]

Notes:

Eden has developed a terpene-based encapsulation technology which uses yeast cells to deliver a slow release of natural compounds for agricultural and non-agricultural uses.

Terpenes are natural compounds which function as defence mechanisms in many plant groups and are released in response to infection, attack by pests, stress or mechanical injury. Terpenes are already widely used in the food flavouring, cosmetic and pharmaceutical industries.

Historically, terpenes have had limited commercial use in the agrochemical sector due to their volatility, phytotoxicity and poor solubility. Eden's platform encapsulation technology provides a unique, environmentally friendly solution to these problems and enables terpenes to be used as effective, low-risk agrochemicals.

The next-generation encapsulation technology, licensed from University of Massachusetts Medical School ("UMMS") recently, provides significant additional benefits to the original system as it allows release to be controlled by environmental factors rather than relying solely upon the chemistry of the substances used. This means that there is more control over the timing of the release of the active compound being carried allowing for further reduction in chemicals applied whilst ensuring maximum effectiveness.

The UMMS license also significantly expands the potential use of the Eden technology in non-agricultural applications such as health and beauty, cosmetics and animal health.

For more information about Eden, please visit www.edenresearch.com 

 

END

 

 

MSCBPBRTMBBMBJT